High Pathologic Complete Response in Her2-Positive, Early-Stage Breast Cancer to a Novel Nonanthracycline Neoadjuvant Chemotherapy

Early Stage ◽

Complete Response ◽

Her2 Positive

Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2‐Positive Early Stage Breast Cancer: A Single Center Experience

The Oncologist ◽

10.1634/theoncologist.2016-0268 ◽

2017 ◽

Vol 22 (2) ◽

pp. 139-143 ◽

Cited By ~ 13

Author(s):

Jasmeet C. Singh ◽

Anita Mamtani ◽

Andrea Barrio ◽

Monica Morrow ◽

Steven Sugarman ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Complete Response ◽

Single Center ◽

Her2 Positive ◽

Single Center Experience

Abstract P2-16-06: In-breast pathologic complete response (pCR) following neoadjuvant chemotherapy predicts nodal pCR in early stage breast cancer

10.1158/1538-7445.sabcs19-p2-16-06 ◽

2020 ◽

Author(s):

Achraf Shamseddine ◽

Jessica Flynn ◽

Zhigang Zhang ◽

Monica Morrow ◽

Boris Mueller ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Complete Response ◽

Impact of pathologic complete response on survival after neoadjuvant chemotherapy in early-stage breast cancer: a population-based analysis

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-019-03083-y ◽

2019 ◽

Vol 146 (2) ◽

pp. 529-536 ◽

Cited By ~ 3

Author(s):

Nathalie LeVasseur ◽

J. Sun ◽

L. Gondara ◽

R. Diocee ◽

C. Speers ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Complete Response ◽

Population Based ◽

Trial-level prediction of long-term outcome based on pathologic complete response (pCR) after neoadjuvant chemotherapy for early-stage breast cancer (EBC)

Contemporary Clinical Trials ◽

10.1016/j.cct.2018.06.016 ◽

2018 ◽

Vol 71 ◽

pp. 194-198 ◽

Cited By ~ 4

Author(s):

Valentina Nekljudova ◽

Sibylle Loibl ◽

Gunter von Minckwitz ◽

Andreas Schneeweiss ◽

Stefan Glück ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Complete Response ◽

Term Outcome ◽

Long Term Outcome

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer

JAMA Oncology ◽

10.1001/jamaoncol.2019.6650 ◽

2020 ◽

Vol 6 (5) ◽

pp. 676 ◽

Cited By ~ 35

Author(s):

Rita Nanda ◽

Minetta C. Liu ◽

Christina Yau ◽

Rebecca Shatsky ◽

Lajos Pusztai ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Complete Response ◽

Abstract P1-14-17: Pathologic complete response rate with doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-positive early stage breast cancer: A single institution experience

10.1158/1538-7445.sabcs15-p1-14-17 ◽

2016 ◽

Author(s):

JC Singh ◽

S Sugarman ◽

L Jones ◽

C Boafo ◽

S Patil ◽

...

Keyword(s):

Breast Cancer ◽

Response Rate ◽

Complete Response Rate ◽

Early Stage ◽

Complete Response ◽

Single Institution ◽

Her2 Positive ◽

Pathologic Complete Response Rate

Abstract P6-07-30: The clinical significance of pathologic complete response using different definitions after neoadjuvant chemotherapy in HER2 positive breast cancer patients according to hormonal receptor status.

10.1158/0008-5472.sabcs12-p6-07-30 ◽

2012 ◽

Author(s):

M Tanioka ◽

K Hirokaga ◽

A Kitao ◽

K Matsumoto ◽

S Yoshida ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Clinical Significance ◽

Complete Response ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Hormonal Receptor Status ◽

Positive Breast Cancer

Abstract P3-11-14: Circulating lymphocytes and pathologic complete response rate among patients with early stage triple negative breast cancer treated with neoadjuvant chemotherapy

10.1158/1538-7445.sabcs18-p3-11-14 ◽

2019 ◽

Author(s):

SM Talamantes ◽

RL Costa ◽

A Rademaker ◽

CA Santa-Maria

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Response Rate ◽

Complete Response Rate ◽

Early Stage ◽

Complete Response ◽

Circulating Lymphocytes ◽

Pathologic Complete Response Rate

Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of rates of pathologic complete response and survival

Journal of Chemotherapy ◽

10.1179/1973947815y.0000000061 ◽

2016 ◽

Vol 28 (3) ◽

pp. 210-217 ◽

Cited By ~ 9

Author(s):

Peter Kern ◽

Anne Kalisch ◽

Gunter von Minckwitz ◽

Carolin Pütter ◽

Hans-Christian Kolberg ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Early Stage ◽

Complete Response ◽

Pathologic Complete Response to Neoadjuvant Chemotherapy Plus Trastuzumab Predicts for Improved Survival in Women With HER2-positive Breast Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.07.594 ◽

2012 ◽

Vol 84 (3) ◽

pp. S229

Author(s):

M.M. Kim ◽

P. Allen ◽

A. Gonzalez-Angulo ◽

W.A. Woodward ◽

F. Meric-Bernstam ◽

...

Keyword(s):

Breast Cancer ◽

Complete Response ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Response To Neoadjuvant Chemotherapy ◽

Positive Breast Cancer